AIFF
AIFF
NASDAQ · Health Care

Firefly Neuroscience Inc

$2.19
+0.01 (+0.46%)
Financial Highlights (FY 2026)
Revenue
462.9K
Net Income
-44,825,953
Gross Margin
32.7%
Profit Margin
-9,685.2%
Rev Growth
-80.7%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 32.7% 32.7% 60.8% 60.8%
Operating Margin -9,309.3% -8,378.3% 16.3% 14.6%
Profit Margin -9,685.2% -9,200.9% 13.5% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 462.9K 2.40M 3.88M 4.00M
Gross Profit 151.6K 785.5K 2.36M 2.43M
Operating Income -43,095,636 -200,964,105 632.7K 584.7K
Net Income -44,825,953 -209,032,941 521.8K 498.1K
Gross Margin 32.7% 32.7% 60.8% 60.8%
Operating Margin -9,309.3% -8,378.3% 16.3% 14.6%
Profit Margin -9,685.2% -9,200.9% 13.5% 12.5%
Rev Growth -80.7% -80.7% -0.8% -2.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 3.88M 3.88M 2.46M 2.16M
Total Equity 17.59M 17.59M 7.46M 6.84M
D/E Ratio 0.22 0.22 0.33 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -43,613,910 -214,679,867 825.5K 921.5K
Free Cash Flow 314.5K 247.7K